CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
Naltrexone and bupropion combination +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02317744
NCT02317744N/ACompleted
CompareCT.gov

Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo

Yale University·interventional·Posted Dec 16, 2014·Updated Dec 22, 2017

In Brief

A clinical study evaluating Naltrexone and bupropion combination and Pill Placebo for Binge Eating Disorder. Completed, enrolled 22 participants across 1 site.

Detailed Summary

This study will test the effectiveness of the combination of Naltrexone and Bupropion relative to placebo for reducing binge eating in persons with obesity and binge eating disorder.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBinge Eating Disorder
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 16, 2014
Enrollment StartDec 1, 2014
Primary CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 11.5 years ago

Interventions

Naltrexone and bupropion combinationdrug

Pill Placeboother